European Medicines Agency Grants Orphan Drug Designation to Nuvisertib for Myelofibrosis
First Patient Dosed in Clinical Trial of An Engineered B-Cell Medicine for Hemophilia B
FDA Approves Extended Indication for Concizumab-Mtci for Hemophilia A and B